Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation

Haematologica

Volumn 82, Issue 1, 1997, Pages 71-72

  Catalano, Lucio ^a   Fontana, Raffaele ^a   Scarpato, Nicola ^a   Picardi, Marco ^a   Rocco, Stefano ^a   Rotoli, Bruno ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Divisione di Ematologia   (Italy)

Author keywords

Aplastic anemia; Aspergillosis; Bone marrow transplantation; G CSF; Granulocyte transfusion

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; ITRACONAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APHERESIS; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; CASE REPORT; DONOR; GRAFT VERSUS HOST REACTION; GRANULOCYTE TRANSFUSION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; REMISSION;

ACYCLOVIR; ADULT; AMPHOTERICIN B; ANEMIA, APLASTIC; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FILGRASTIM; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; LEUKOCYTE TRANSFUSION; LUNG DISEASES, FUNGAL; MALE; RECOMBINANT PROTEINS; REMISSION INDUCTION;

EID: 0031450248     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bacigalupo A. Guidelines for the treatment of severe aplastic anemia. Haematologica 1994; 79:438-44.
2. Saral R. Candida and Aspergillus infections in immunocompromised patients. Rev Infect Dis 1991; 13:487-92.
3. Denning DW. The treatment of invasive aspergillosis. J Infect 1994; 28(suppl 1):25-33.
4. Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD. Granulocyte transfusions for the prevention of infection in patients receiving bone marrow transplants. N Engl J Med 1978; 298:1052-7.
5. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81:1883-8.
6. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993; 81:2866-71.
7. Katoh M, Takada M, Nakatoni N, Cho C, Umeda M. Chemotaxis and phagocytosis of the neutrophils mobilized by granulocyte colony-stimulating factors in healthy donors for granulocyte transfusion. Am J Hematol 1995; 49:96-7.
8. Freireich EJ. White cell transfusions born again. Leuk Lymphoma 1993;11(Suppl 2):161-5.
9. Strauss RG, Connett JE, Gale RP, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 1981; 305:597-602.
10. Vannucchi AM, Bosi A, Laszlo D, Guidi S, Saccardi R, Rossi Ferrini P. Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSF. Haematologica 1995; 80: 341-3.